On the heels of the United States Food and Drug Administration approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there.
Learn more at:
Health Canada Approves PRADAX as Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation